“It’s a wonderful time to be a CMO in the B2B world,” suggested Margaret Molloy, in a recent Forbes article. The role is rapidly changing and those marketers who can lead the change are poised to have ...

Instead of B2B organizations putting all their information cards on the table for revenue planning, many company executives are opaque about the growth strategies, go-to-market approach and ...

Discover how marginal cost and revenue calculations help businesses find their profit-maximizing point by comparing costs and ...

According to the latest State of Revenue survey of c-suite executives, pharma manufacturers are prioritizing digital transformation while struggling with inflation and supply chain disruptions.

Increased patient financial responsibility, difficult patient collections and value-based reimbursement models have presented significant financial challenges for hospitals and health care providers.

According to the 2023 State of Revenue Report, pharma companies are prioritizing digital transformation while struggling with inflation and supply chain disruptions. Entering 2023, pharma executives ...

We are writing to express our concern about Revenue Ruling 2004-6, and urge you to adopt a bright-line rule regarding what is and is not an ""exempt function"" within the meaning of §527(e)(2) of the ...

Dr B. Yerram Raju, Ph.D., from Andhra University is a banker turned economist having worked with the SBI for nearly three decades. He was Senior Faculty and Dean of ASCI for nearly 8years and ...